Franco Fabio Stellari

Corporate Preclinical R&D

Chiesi Farmaceutici S.p.A.

BIOGRAPHY

Franco Fabio Stellari has not added Biography.

If you are Franco Fabio Stellari and would like to personalize this page please email our Author Liaison for assistance.

PUBLICATIONS

In vivo imaging of the lung inflammatory response to Pseudomonas aeruginosa and its modulation by azithromycin.

Journal of translational medicine Aug, 2015 | Pubmed ID: 26239109

Monitoring inflammation and airway remodeling by fluorescence molecular tomography in a chronic asthma model.

Journal of translational medicine Oct, 2015 | Pubmed ID: 26496719

In vivo monitoring of lung inflammation in CFTR-deficient mice.

Journal of translational medicine Jul, 2016 | Pubmed ID: 27468800

INSTITUTIONS

Chiesi Farmaceutici S.p.A.

JOVE ARTICLES

A Multimodal Imaging Approach Based on Micro-CT and Fluorescence Molecular Tomography for Longitudinal Assessment of Bleomycin-Induced Lung Fibrosis in Mice

Francesca Ruscitti¹,

Francesca Ravanetti²,

Gaetano Donofrio²,

Yanto Ridwan³,

Paula van Heijningen³,

Jeroen Essers⁴,

Gino Villetti¹,

Antonio Cacchioli²,

Wim Vos⁵,

Franco Fabio Stellari¹

¹Corporate Preclinical R&D, Chiesi Farmaceutici S.p.A.,

²Department of Veterinary Science, University of Parma,

³Department of Molecular Genetics, Erasmus MC,

⁴Department of Molecular Genetics, Vascular Surgery, Radiation Oncology, Erasmus MC,

⁵, Fluidda NV

Immunology and Infection

政策

使用条款

隐私

联系我们

向图书馆推荐

JoVE 新闻简报

科研

JoVE Journal
技术专题合集
JoVE Encyclopedia of Experiments
档案

教育

JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
教师资源中心
Faculty Site

发表

概述
发表流程
编辑部
范围和政策
同行评审
常见问题
提交稿件

图书馆员

概述
客户评价
订阅
访问权限
资源
图书馆咨询委员会
常见问题

关于 JoVE

概述
管理层
博客
JoVE Help Center

Franco Fabio Stellari

.css-o250i3{font-size:18px;font-family:Open Sans,sans-serif;line-height:21.6px;}Corporate Preclinical R&D

Chiesi Farmaceutici S.p.A.

A Multimodal Imaging Approach Based on Micro-CT and Fluorescence Molecular Tomography for Longitudinal Assessment of Bleomycin-Induced Lung Fibrosis in Mice

Corporate Preclinical R&D